Skip to main content
. Author manuscript; available in PMC: 2018 May 23.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):205–212. doi: 10.1097/QAI.0000000000001036

Table 1. Percentage of Patients With Suppressed Viral Load According to Method of Measurement, 2012–2013*.

Method of Measurement During 12-Month Observation Period % (n/N)
Single-value method
 % patients who had suppressed viral load on their latest assessment during observation 83.0 (9083/10,942)
 % patients who had suppressed viral load on their first (entry) assessment during observation 75.3 (8238/10,942)
Using all viral loads during observation
 % patients who had all viral loads suppressed (stable suppression) 65.9 (7206/10,942)
 % who had some, but not all, viral loads suppressed 24.9 (2722/10,942)
 % who had no viral loads suppressed 9.3 (1014/10,942)
Maintenance of suppressed viral load
 Among patients whose cohort entry viral load was suppressed, % who had all subsequent viral loads suppressed during observation 87.5 (7206/8238)
Change in status from first to last viral load during observation
 First suppressed/last suppressed 69.7 (7628/10,942)
 First unsuppressed/last unsuppressed 11.4 (1249/10,942)
 First unsuppressed/last suppressed 13.3 (1455/10,942)
 First suppressed/last unsuppressed 5.6 (610/10,942)
*

Cohort patients had at least 2 viral load records during 12 months of observation. There were 69 patients in the cohort who were transgender. These 69 patients were included in the denominators of the outcomes reported in this table.